Top Qs
Timeline
Chat
Perspective

6-Hydroxytryptamine

Pharmaceutical compound From Wikipedia, the free encyclopedia

6-Hydroxytryptamine
Remove ads

6-Hydroxytryptamine (6-HT or 6-HO-T) is a serotonin receptor modulator of the tryptamine family related to serotonin.[1][2][3] It is a positional isomer of serotonin (5-hydroxytryptamine; 5-HT) and of 4-hydroxytryptamine (4-HT).[1][2][3]

Quick Facts Clinical data, Other names ...
Remove ads

Pharmacology

6-Hydroxytryptamine shows dramatically reduced affinity for serotonin receptors, including the serotonin 5-HT1A, 5-HT1B, 5-HT2A, and 5-HT2C receptors (Ki = 1,590 nM, 5,890 nM, 11,500 nM, and 5,500 nM, respectively), compared to serotonin, 4-hydroxytryptamine, 5-methoxytryptamine, and certain other tryptamines.[3] It did not produce hyperlocomotion in rodents but did partially reverse reserpine-induced hypoactivity.[4] 6-Hydroxytryptamine appears to be less susceptible to metabolism by monoamine oxidase (MAO) than serotonin.[5]

Remove ads

History

6-Hydroxytryptamine was first described in the scientific literature by the 1950s.[6]

Derivatives

Certain β-carbolines and harmala alkaloids, such as harmol, harmalol, and tetrahydroharmol, as well as their O-methyl (methoxy) analogues including harmine, harmaline, and tetrahydroharmine, are notable in being naturally occurring cyclized tryptamine derivatives of 6-hydroxytryptamine.[7][8] The same is true of certain iboga alkaloids, such as tabernanthine and ibogaline.[9][10][11][12] Tabernanthalog (DLX-007) is a synthetic simplified ibogalog analogue of tabernanthine that is under development for use as a potential pharmaceutical drug in the treatment of neuropsychiatric disorders.[13][14]

See also

References

Loading related searches...

Wikiwand - on

Seamless Wikipedia browsing. On steroids.

Remove ads